V Square Quantitative Management LLC Purchases 266 Shares of Colgate-Palmolive (NYSE:CL)

V Square Quantitative Management LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,598 shares of the company’s stock after acquiring an additional 266 shares during the period. V Square Quantitative Management LLC’s holdings in Colgate-Palmolive were worth $1,418,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Farmers & Merchants Trust Co of Chambersburg PA increased its position in Colgate-Palmolive by 34.7% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 970 shares of the company’s stock valued at $88,000 after acquiring an additional 250 shares in the last quarter. Asset Management One Co. Ltd. raised its position in Colgate-Palmolive by 4.3% in the 4th quarter. Asset Management One Co. Ltd. now owns 392,938 shares of the company’s stock worth $36,076,000 after purchasing an additional 16,036 shares during the last quarter. Avestar Capital LLC raised its position in Colgate-Palmolive by 14.4% in the 4th quarter. Avestar Capital LLC now owns 5,142 shares of the company’s stock worth $467,000 after purchasing an additional 649 shares during the last quarter. Ingalls & Snyder LLC lifted its holdings in Colgate-Palmolive by 1.2% during the 4th quarter. Ingalls & Snyder LLC now owns 23,557 shares of the company’s stock worth $2,142,000 after buying an additional 282 shares in the last quarter. Finally, McClarren Financial Advisors Inc. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $55,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on CL. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. UBS Group dropped their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $101.16.

View Our Latest Research Report on Colgate-Palmolive

Colgate-Palmolive Stock Up 1.3 %

Shares of CL stock opened at $87.87 on Friday. The firm’s fifty day moving average price is $89.83 and its two-hundred day moving average price is $96.54. Colgate-Palmolive has a 1 year low of $82.83 and a 1 year high of $109.30. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $71.79 billion, a P/E ratio of 24.96, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the prior year, the company earned $0.87 EPS. On average, equities analysts predict that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s payout ratio is 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.